BioCentury
ARTICLE | Clinical News

Menveo regulatory update

March 19, 2012 7:00 AM UTC

EMA's CHMP issued a positive opinion recommending approval of a label expansion for Menveo meningitis vaccine to include children ages 2-11 years of age. The vaccine is already approved to prevent inv...